We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mobix Labs Inc | NASDAQ:MOBX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.06 | 3.21% | 1.93 | 1.88 | 2.00 | 14,291 | 13:36:53 |
Revenue up 44% sequentially and significant Gross Margin expansion
Acquisition strategy successfully expanding end markets and diversifying offerings
Increasing Customer Demand
Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs”, “Mobix” or the “Company”), a leader in advanced connectivity solutions, today announced financial results for its fiscal fourth quarter and year ended September 30, 2024.
“We are pleased to announce a successful fiscal fourth quarter that caps off Mobix Labs’ results as we complete our first year as a public company,” said Fabian Battaglia, CEO of Mobix Labs. “I’m proud of our team’s execution as we are quickly growing the breadth of our offerings and targeting synergistic accretive acquisitions. Integrating technologies and businesses is part of our core DNA, and shaping tomorrow’s connectivity is front and center for Mobix.”
“We were pleased with both our revenue growth of 426% for the fiscal year and our gross margin expansion,” commented Keyvan Samini, President and CFO of Mobix Labs. “Fiscal 2024 was a transformative year and as we begin 2025, we are pursuing additional financing to fuel our acquisition strategy and to provide for working capital to fulfill our strong customer demand.”
Financial Highlights for Fourth Quarter of 2024
Financial Highlights for Fiscal Year 2024
Recent Business Highlights
Financial Outlook
Net revenues are expected to fall within a range of $3.05 - $3.15 million in the fiscal first quarter of 2025.
Non-GAAP Financial Measures
In addition to reporting financial results in accordance with U.S. generally accepted accounting principles (GAAP), the Company uses certain non-GAAP measures of financial performance, including:
The Company’s management believes it is useful to consider these non-GAAP financial measures, together with the corresponding GAAP financial measures, as they provide more transparency into current business trends, exclusive of the effects of certain non-cash expenses, acquisition-related charges, and items that may not be present in comparative fiscal periods. Management believes that, when considered together with reported GAAP financial measures, these non-GAAP financial measures are useful to investors and management in understanding the Company’s ongoing operations and operating trends and in analyzing the Company’s underlying financial performance.
These non-GAAP financial measures are not intended to be considered in isolation from, as a substitute for, or superior to, the comparable GAAP measures. These non-GAAP financial measures may be different from similarly titled measures used by other companies. In the future, Mobix may consider whether other items should also be excluded in calculating the non-GAAP financial measures it uses. Management believes that the presentation of these non-GAAP financial measures provides investors with additional useful information to measure Mobix Labs’ financial and operating performance. In particular, these measures facilitate comparison of our operating performance between periods and may help investors to understand better our operating results. Internally, management uses these non-GAAP financial measures in assessing the Company's operating results and in planning and forecasting. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measure is contained in the financial tables to this press release.
Conference Call Information
Event:
Mobix Labs, Inc. Fourth Quarter 2024 Earnings Call
Date:
Thursday, December 19, 2024
Time:
2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time
Webcast:
investors.mobixlabs.com
Dial-in number:
https://register.vevent.com/register/BI37e4d59b857d4ae697e3f80cd43b40d1
Shortly after the completion of the conference call, an archived version of the webcast will be available on the Company’s investor relations website at investors.mobixlabs.com.
About Mobix Labs, Inc.
Mobix Labs designs, develops and sells components and systems for advanced wireless and wired connectivity, radio frequency (“RF”), switching and electromagnetic interference (“EMI”) filtering technologies. Our solutions are used in the consumer commercial, industrial, automotive, medical, aerospace, defense and other markets. To enhance our product portfolio, we also intend to pursue acquisitions of companies with existing revenue which can be scaled, and which possess technologies that accelerate the speed, accessibility, and efficiency of disruptive or more efficient communications solutions, and which will also allow us to expand into strategically aligned industries. Our wireless systems solutions include products for advanced RF and millimeter wave (“mmWave”) 5G communications, mmWave imaging, software defined radio and custom RF integrated circuits (“ICs”) targeting the commercial, industrial, and defense and aerospace sectors. Our interconnect products, including EMI filter inserts and filtered and non-filtered connectors, are designed for and are currently used in aerospace, military, defense and medical applications. Our True Xero active optical cables (“AOCs”) are designed to meet customer needs for high-quality active optical cable solutions at an affordable price. These innovative technologies are designed for large and rapidly growing markets where there is increasing demand for higher performance communication and filtering systems which utilize an expanding mix of both wireless and connectivity technologies.
Mobix Labs and the logo, are among the trademarks of Mobix Labs. Other trademarks are the property of their respective owners.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about (i) our expectations regarding customer demand and requests for proposals as well as our ability to expand our customer base and product offerings; (ii) our financial outlook, including expectations regarding revenue growth and adjusted loss from operations; (iii) our ability to secure additional financing and any strategic initiatives, specifically with respect to synergistic product acquisitions; (iv) our expectations regarding our intent to acquire Spacecraft and any other possible acquisitions and (v) the impact of any strategic partnerships on our business, are forward-looking statements. Although Mobix Labs believes that the expectations reflected in the forward-looking statements are reasonable, Mobix Labs cannot guarantee future results, levels of activity, performance, achievements, or events and circumstances reflected in the forward-looking statements will occur. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. As a result of a number of known and unknown risks and uncertainties, the actual results or performance of Mobix Labs may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include our ability to enter into a definitive agreement to acquire Spacecraft, as well as our ability to meet the closing conditions to acquire Spacecraft; the inability to meet future capital requirements and risks related to Mobix Labs’ ability to raise additional capital; the risk that Mobix Labs is unable to successfully commercialize its products and solutions, or experience significant delays in doing so; the risk that Mobix Labs may not be able to generate income from operations in the foreseeable future; the risks concerning Mobix Labs’ ability to continue as a going concern; the inability to maintain the listing of Mobix Labs’ securities on Nasdaq; the risk that the price of Mobix Labs’ securities may be volatile due to a variety of factors, including changes in the highly competitive industries in which Mobix Labs operates, variations in performance across competitors, changes in laws, regulations, technologies, the global supply chain, and macro-economic and social environments affecting Mobix Labs’ business and changes in the combined capital structure; the risk that Mobix Labs experiences difficulties in managing its growth and expanding operations; the risk that Mobix Labs may not be able to consummate planned strategic acquisitions, or fully realize anticipated benefits from past or future acquisitions or investments; the risk that litigation may be commenced against Mobix Labs; the risk that Mobix Labs’ patent applications may not be approved or may take longer than expected, and Mobix Labs may incur substantial costs in enforcing and protecting its intellectual property; Mobix Labs’ reliance on a limited number of customers and retaining those customers; the impact of health epidemics, such as the COVID-19 pandemic, on Mobix Labs’ business and industry and the actions Mobix Labs may take in response thereto and to other geopolitical concerns; and in some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on August 14, 2024, and in any subsequent filings with the SEC. All information provided in this press release is as of the date of this press release, and Mobix Labs undertakes no duty to update such information, except as required under applicable law.
Mobix Labs, Inc. Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited, in thousands, except share and per share amounts) Three months ended September 30, Year ended September 30,2024
2023
2024
2023
Net revenue$
2,954
$
433
$
6,442
$
1,224
Cost of revenue
1,282
432
3,890
1,620
Gross profit
1,672
1
2,552
(396
)
Research and development
1,451
1,835
5,779
11,044
Selling, general and administrative
10,104
2,906
41,835
24,104
Impairment of long-lived assets
1,333
-
1,333
-
Loss from operations
(11,216
)
(4,740
)
(46,395
)
(35,544
)
Interest expense
350
2,169
1,582
3,355
Change in fair value of earnout liability
(1,280
)
-
(31,879
)
-
Change in fair value of PIPE make-whole liability
(708
)
-
(830
)
-
Change in fair value of SAFEs
-
127
10
655
Merger-related transaction costs expensed
-
-
4,009
-
Private placement costs
2,894
-
2,894
-
Other non-operating losses, net
(1,307
)
-
282
-
Loss before income taxes
(11,165
)
(7,036
)
(22,463
)
(39,554
)
Provision (benefit) for income taxes
372
49
(2,429
)
67
Net loss and comprehensive loss
(11,537
)
(7,085
)
(20,034
)
(39,621
)
Deemed dividend
-
-
661
-
Net loss available to common stockholders
$
(11,537
)
$
(7,085
)
$
(20,695
)
$
(39,621
)
Net loss per common share: Basic$
(0.34
)
$
(0.42
)
$
(0.73
)
$
(2.71
)
Diluted$
(0.35
)
$
(0.42
)
$
(0.75
)
$
(2.71
)
Weighted-average common shares outstanding: Basic
34,258,869
16,705,331
28,419,593
14,612,600
Diluted
34,956,411
16,705,331
29,483,021
14,612,600
Mobix Labs, Inc. Reconciliation of Non-GAAP Financial Measures (unaudited, in thousands) Three Months Ended Year Ended September 30, September 30,
2024
2023
2024
2023
Computation of Adjusted Loss from Operations: GAAP loss from operations$
(11,216
)
$
(4,740
)
$
(46,395
)
$
(35,544
)
Depreciation
115
112
472
449
Amortization of acquisition related intangible assets
426
210
1,543
841
Merger & acquisition-related expenses
2,088
19
5,579
90
Inventory write-off
-
-
125
-
Stock-based compensation expense
3,615
1,089
21,383
15,476
Impairment of long-lived assets
1,333
-
1,333
-
Adjusted loss from operations
$
(3,639
)
$
(3,310
)
$
(15,960
)
$
(18,688
)
Three Months Ended Year Ended September 30, September 30,2024
2023
2024
2023
GAAP gross profit: GAAP net revenue$
2,954
$
433
$
6,442
$
1,224
GAAP cost of revenue
1,282
432
3,890
1,620
GAAP gross profit
$
1,672
$
1
$
2,552
$
(396
)
GAAP gross margin %
56.6
%
0.2
%
39.6
%
-32.4
%
Computation of Adjusted Gross Profit: GAAP gross profit$
1,672
$
1
$
2,552
$
(396
)
Amortization of acquisition-related intangible assets
11
67
219
271
Inventory write-off
-
-
125
-
Stock-based compensation expense
(12
)
(3
)
15
31
Adjusted Gross Profit
$
1,671
$
65
$
2,911
$
(94
)
Adjusted Gross Margin %
56.6
%
15.0
%
45.2
%
-7.7
%
Mobix Labs, Inc. Condensed Consolidated Balance Sheets (unaudited, in thousands, except share and per share amounts)September 30,
2024
2023
ASSETS Current assets Cash$
266
$
89
Accounts receivable, net
2,813
53
Inventory
1,725
319
Prepaid expenses and other current assets
467
369
Total current assets
5,271
830
Property and equipment, net
1,177
1,859
Intangible assets, net
15,211
5,287
Goodwill
16,066
5,217
Operating lease right-of-use assets
1,022
1,030
Deferred transaction costs
-
4,125
Other assets
341
400
Total assets
$
39,088
$
18,748
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Current liabilities Accounts payable
$
10,833
$
8,995
Accrued expenses and other current liabilities
10,325
4,519
Deferred purchase consideration
2,380
-
Notes payable
398
1,286
Notes payable - related parties
1,743
3,793
Simple agreements for future equity
-
1,512
Operating lease liabilities, current
428
318
Total current liabilities
26,107
20,423
Notes payable, noncurrent
200
-
Notes payable - related parties, noncurrent
1,082
-
Earnout liability
1,680
-
Deferred tax liability
320
86
Operating lease liabilities, noncurrent
1,024
1,280
Other noncurrent liabilities
3,145
-
Total liabilities
33,558
21,789
Redeemable convertible preferred stock
-
2,300
Stockholders' equity (deficit) Common stock, $0.00001 par value
-
-
Additional paid-in capital
109,987
78,421
Accumulated deficit
(104,457
)
(83,762
)
Total stockholders' equity (deficit)
5,530
(5,341
)
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)$
39,088
$
18,748
View source version on businesswire.com: https://www.businesswire.com/news/home/20241219704692/en/
Investor Contact: investors@mobixlabs.com
1 Year Mobix Labs Chart |
1 Month Mobix Labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions